返回 Agenda
Session Chair(s)
Vratislav Hadrava, MD, PHD
Vice President and Medical Director, Global Innovative Products
Pfizer Canada, Inc., Canada
Speaker(s)
Health Canada Perspective
Kelly Robinson, MSC
Health Canada, Canada
Director General, Pharmaceutical Drugs Directorate
Health Technology Assessment (HTA) Perspective
Mona Sabharwal
pCODR (pan-Canadian Oncology Drug Review) at CADTH, Canada
Executive Director
Industry Perspective
Christine Mormont, PHD
Merck Canada, Canada
Director, Medical Affairs - Oncology